XML 14 R4.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenue:    
Total net revenues $ 73,137 $ 68,522
Cost of goods sold $ 24,240 $ 21,867
Cost, Product and Service [Extensible Enumeration] Product revenue, net Product revenue, net
Gross profit $ 48,897 $ 46,655
Operating expenses:    
Selling, general and administrative 51,981 56,640
Research and development 2,240 2,212
Revaluation of contingent royalty obligation payable to Evolus Founders (14) 2,151
Depreciation and amortization 1,538 824
Total operating expenses 55,745 61,827
Loss from operations (6,848) (15,172)
Other income (expense):    
Interest income 285 710
Interest expense (3,975) (4,415)
Other income (expense), net 120 57
Loss before income taxes (10,418) (18,820)
Income tax expense (256) (72)
Net loss (10,674) (18,892)
Other comprehensive income (loss), net of tax:    
Currency translation adjustment (122) 66
Comprehensive loss $ (10,796) $ (18,826)
Net loss per share, basic (in dollars per share) $ (0.16) $ (0.30)
Net loss per share, diluted (in dollars per share) $ (0.16) $ (0.30)
Weighted-average shares outstanding used to compute basic net loss per share (in shares) 65,186,643 63,696,627
Weighted-average shares outstanding used to compute diluted net loss per share (in shares) 65,186,643 63,696,627
Product revenue, net    
Revenue:    
Total net revenues $ 72,747 $ 68,074
Service revenue    
Revenue:    
Total net revenues $ 390 $ 448